1. Glioblastoma antigen discovery—foundations for immunotherapy
   Tej D. Azad et al, 2015, Journal of Neuro-Oncology CrossRef
2. Receptor-Targeted Glial Brain Tumor Therapies
   Puja Sharma et al, 2018, International Journal of Molecular Sciences CrossRef
3. TRP-2 / gp100 DNA vaccine and PD-1 checkpoint blockade combination for the treatment of intracranial tumors
   Joshua R. D. Pearson et al, 2024, Cancer Immunology, Immunotherapy CrossRef
4. Novel cancer antigens for personalized immunotherapies: latest evidence and clinical potential
   Gregory T. Wurz et al, 2016, Therapeutic Advances in Medical Oncology CrossRef
5. Vaccination strategies for neuro-oncology: Table 1.
   John H. Sampson et al, 2015, Neuro-Oncology CrossRef
6. An Overview of High-grade Glioma: Current and Emerging Treatment Approaches
   S.G. Kavya et al, 2021, Current Cancer Therapy Reviews CrossRef
7. Selection of suitable reference genes for expression analysis in human glioma using RT-qPCR
   Susanne Grube et al, 2015, Journal of Neuro-Oncology CrossRef
8. Immunotherapy for High-Grade Gliomas
   Teilo H. Schaller et al, 2017, Malignant Brain Tumors CrossRef
9. Role of Kinetochore Scaffold 1 (KNL1) in Tumorigenesis and Tumor Immune Microenvironment in Pan-Cancer: Bioinformatics Analyses and Validation of Expression
   Yixin Ding et al, 2023, International Journal of General Medicine CrossRef
10. A172 and T98G cell lines characteristics
    L. N. Kiseleva et al, 2016, Cell and Tissue Biology CrossRef
11. Integrated mRNAseq and microRNAseq data analysis for grade III gliomas
    Junqiang Dai et al, 2017, Molecular Medicine Reports CrossRef
12. Quo Vadis—Do Immunotherapies Have a Role in Glioblastoma?
    Sylvia C. Kurz et al, 2018, Current Treatment Options in Neurology CrossRef
13. Putative RNA-directed adaptive mutations in cancer evolution
    Didier Auboeuf, 2016, Transcription CrossRef
14. Hijacking Sexual Immuno-Privilege in GBM—An Immuno-Evasion Strategy
    Martyn A. Sharpe et al, 2021, International Journal of Molecular Sciences CrossRef
15. Advances and challenges: dendritic cell vaccination strategies for glioblastoma
    Teilo H. Schaller et al, 2017, Expert Review of Vaccines CrossRef
16. Inhibiting microcephaly genes as alternative to microtubule targeting agents to treat brain tumors
    Giorgia Iegiani et al, 2021, Cell Death & Disease CrossRef
17. The different role of YKL-40 in glioblastoma is a function of MGMT promoter methylation status
    Wei-jun Chen et al, 2020, Cell Death & Disease CrossRef
18. Engineering challenges for brain tumor immunotherapy
    Johnathan G. Lyon et al, 2017, Advanced Drug Delivery Reviews CrossRef
19. Construction of IL-13 Receptor α2-Targeting Resveratrol Nanoparticles against Glioblastoma Cells: Therapeutic Efficacy and Molecular Effects
    Xiao-Min Lin et al, 2021, International Journal of Molecular Sciences CrossRef
20. Neonatal Porcine Germ Cells Dedifferentiate and Display Osteogenic and Pluripotency Properties
    Mohammad Amin Fayaz et al, 2021, Cells CrossRef
21. RETRACTED: NY-SAR-35 is involved in apoptosis, cell migration, invasion and epithelial to mesenchymal transition in glioma
    Guangyong Wu et al, 2018, Biomedicine & Pharmacotherapy CrossRef
22. Identification of key modules and hub genes in glioblastoma multiforme based on co‐expression network analysis
    Chun Li et al, 2021, FEBS Open Bio CrossRef